Today’s pharmaceutical industry is teetering between an innovation renaissance and an affordability crisis. Investment analyst Craig Gordon, a former practicing physician, takes us inside the complex world of pharma and biotech, where the interests of doctors, patients, insurers and policymakers can often be at odds.
Listen and learn:
Your host, Matt Miller, is the policy and communications advisor for Capital Group. An author and former Washington Post columnist, Matt was co-host of the public radio program Left, Right & Center.
This content is published by Capital Client Group, Inc.
Do you have any topics for Capital Ideas? Please contact our editorial team at CapitalIdeas@capgroup.com.
Related Global Companies: The Power of Deep Distribution Networks
